-
Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'
Monday, December 5, 2022 - 9:23am | 233Read More...The iShares Biotechnology ETF (NASDAQ: IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to around 10%. On CNBC’s “Halftime Report Final Trades,” Jeffrey Mills of Bryn Mawr Trust recommended going long on biotech stocks. Check out...
-
Why Apple Could Fall Another 11%: Fundamentals & Technicals Suggest Investors Should Stay Away
Friday, May 13, 2016 - 4:38pm | 385Read More...Shares of Apple Inc. (NASDAQ: AAPL) have been trading close to two-year lows in the past few days. On Thursday, the stock hit lowest point since June 2014. Following this event, Oppenheimer technical analyst Ari Wald and Bryn Mawr Trust's chief investment officer Ernie Cecilia were on CNBC to...
-
Analyst Recommends 3M And Caterpillar (MMM, CAT, CSCO, ATT)
Friday, June 18, 2010 - 1:21pm | 153Read More...Chip Cobb, senior vice president at Bryn Mawr Trust, discussed his market outlook with CNBC. He said, “Unfortunately, we’re stuck in a trading range and I think we’re going to be here for a while. Primarily, there’s a lot of pressure that we’re dealing with and most of it is headline risk.” He said...
